Singleplex Immunoassay Market Research Report – Forecast to 2023

Global Singleplex Immunoassay Market Research Report: By Products and Services (Consumables, Others), by Type (Protein-Based Assays, Nucleic Acid Based Assays, Others), Technology (Flow Cytometry, Others), Application, End-User - Global Forecast Till 2023

ID: MRFR/LS/4737-HCR | February 2021 | Region: Global | 100 pages

Market Scenario


The global singleplex immunoassay market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global singleplex immunoassay market is expected to register a CAGR ~ 8.4 % during the forecast period of 2018–2023.


Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification. For instance, Thermo Fisher Scientific’s QuantiGene Singleplex assay is developed to detect original RNA or DNA population using signal amplification.


Numerous factors such as growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, and rising use of immunoassay in oncology fuels the growth of global singleplex immunoassay. Additionally, that rising prevalence of chronic diseases will push the demand for singleplex immunoassay technologies.


Moreover, the growing awareness about immunoassay, enhanced focus on diagnostic testing, and increasing government assistance are continuously contributing to the growth of the global singleplex immunoassay market.


Despite the drivers, some factors such as the stringent FDA regulations, the emergence of multiplex immunoassays, the complex procedure of testing, and poor healthcare system in low and middle-income countries may hamper the growth of the market to an extent.


Company Profiles    



  • Luminex

  • Thermo Fisher Scientific

  • Illumina

  • Bio-Rad Laboratories

  • QIAGEN N.V

  • Abcam

  • Becton Dickinson and Company

  • Merck Life sciences

  • Agilent Technologies

  • Quanterix

  • Bio-Techne

  • Olink

  • Seegene

  • BioVendor

  • Others


Segmentation


The global singleplex immunoassay market is segmented on the basis of the product and service, type, technology, application, and end-user.


On the basis of the product and services, the market is classified as consumables, instruments, and others.


The global singleplex immunoassay market on the basis of the type is segmented as protein-based assays, nucleic acid-based assays, cell-based assays, and others.


On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, and others.


The global singleplex immunoassay market, by application, is segmented into research and development, clinical diagnostics, and others. The research and development are further segmented into drug discovery & development and biomarker discovery and validation. The clinical diagnostics are further segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and metabolism & endocrinology disorders.


On the basis of the end-user, the global singleplex immunoassay market is segmented as pharmaceutical & biotechnology companies, hospitals & research institutes, reference laboratories and others.


Geographically, global singleplex immunoassay market has been segmented into America, Europe, Asia-Pacific, and the Middle East & Africa. The Americas singleplex immunoassay market is further segmented into North America, and South America. North America is further classified as the US and Canada.


The Europe singleplex immunoassay market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UKUK, Italy, Spain, and the Rest of Western Europe.


The Asia-Pacific singleplex immunoassay market is segmented into Japan, China, India, Republic of Korea, Australia, and Rest of Asia-Pacific.


The Middle East & Africa singleplex immunoassay market is segmented into the Middle East, and Africa.


Regional Market Summary


Global Singleplex Immunoassay Market, by Region Market Share, 2017 (%)


 Singleplex Immunoassay Market


Source: MRFR Analysis


The global singleplex immunoassay market consists of four regions: Americas, Europe, Asia-Pacific and the Middle East & Africa. The Americas is expected to dominate the singleplex immunoassay market owing to the presence of major market players, high adoption rate, and increasing prevalence of infectious diseases. According to the statistics suggested by the Centers for Disease Control (CDC) and Prevention, in 2014,  around 9,421 cases of tuberculosis, 51,455 cases of salmonella, 33,461 cases of Lyme disease, and 433 cases of meningococcal disease were registered in the United States.


Europe is anticipated to hold the second position in the global singleplex immunoassay market. It is expected that the rising automation in an immunoassay, increasing prevalence of chronic diseases, funding provided by the government, and private organizations towards research & development are anticipated to drive the European market.


The Asia-Pacific singleplex immunoassay market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is the fastest growing in singleplex immunoassay market. Major factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in the biotechnology sector, increasing healthcare expenditure influences the market in this region. Additionally, according to the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was USD 170.4 billion, i.e., 3.6 % higher than the expenditure of 2014-2015.


The Middle East and Africa hold the least share in the global singleplex immunoassay market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth.


 


Research Methodology


Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.



  • Primary Research


The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global singleplex immunoassay market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.


Global Singleplex Immunoassay Market, by Product and Service



  • Consumables

  • Instruments

  • Others


Global Singleplex Immunoassay Market, by Type



  • Protein-Based Assays

  • Nucleic Acid Based Assays

  • Cell-Based Assays

  • Others


Global Singleplex Immunoassay Market, by Technology



  • Flow Cytometry

  • Fluorescence Detection


Global Singleplex Immunoassay Market, by Application



  • Research & Development

  • Drug Discovery & Development

  • Biomarker Discovery & Validation

  • Clinical Diagnostics

  • Infectious Diseases

  • Cancer

  • Cardiovascular Diseases

  • Autoimmune Diseases

  • Nervous System Disorders

  • Metabolism & Endocrinology Disorders

  • Others


Global Singleplex Immunoassay Market, by End-user



  • Pharmaceutical & Biotechnology Companies

  • Hospitals & Research Institutes

  • Reference Laboratories

  • Others


Global Singleplex Immunoassay Market, by Region



  • Americas

  • North America

  • US

  • Canada

  • South America

  • Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe

  • Asia-Pacific

  • Japan

  • China

  • India

  • Australia

  • Republic of Korea

  • Rest of Asia-Pacific

  • The Middle East & Africa

  • Middle East

  • Africa


Intended Audience



  • Pharmaceutical Companies

  • Medical Device Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities



Frequently Asked Questions (FAQ) :


Singleplex Immunoassay Market is projected to grow at an 8.4% CAGR between 2018-2023.

The Americas is expected to lead the Singleplex Immunoassay Market.

Rising prevalence of chronic diseases and growing biotechnology sector is boosting market growth.

Poor healthcare system may limit market growth.

Different strategies used by market players to create a dominance in the Singleplex Immunoassay Market growth include mergers, collaborations, product developments, and R&D.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Singleplex Immunoassay Market, by Product and Service

6.1 Introduction

6.2 Consumables

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Instruments

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 7. Global Singleplex Immunoassay Market, by Type

7.1 Introduction

7.2 Protein-Based Assays

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Nucleic Acid Based Assays

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Cell-Based Assays

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.5 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 8. Global Singleplex Immunoassay Market, by Technology

8.1 Introduction

8.2 Flow Cytometry

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Fluorescence Detection

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Singleplex Immunoassay Market, by Application

9.1 Introduction

9.2 Research & Development

9.2.1 Drug Discovery & Development

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.2.2 Biomarker Discovery & validation

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3 Clinical Diagnostics

9.3.1 Infectious Diseases

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3.2 Cancer

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3.3 Cardiovascular Diseases

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3.4 Autoimmune Diseases

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3.5 Nervous System Disorders

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3.6 Metabolism & Endocrinology Disorders

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.4 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 10. Global Singleplex Immunoassay Market, by End-User

10.1 Introduction

10.2 Pharmaceuticals & Biotechnology Companies

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

10.3 Hospital & Research Institutes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

10.4 Reference Laboratories

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

10.5 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 11. Global Singleplex Immunoassay Market, by Region

11.1 Introduction

11.2 Americas

11.2.1 North America

11.2.1.1 US

11.2.1.2 Canada

11.2.2 South America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 UK

11.3.1.6 Rest of Western Europe

11.3.2 Eastern Europe

11.4 Asia Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 Republic of Korea

11.4.6 Rest of Asia Pacific

11.5 The Middle East & Africa

11.5.1 The Middle East

11.5.2 Africa

Chapter 12. Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

Chapter 13. Company Profiles

13.1 Luminex

13.1.1 Company Overview

13.1.2 Product Overview

13.1.3 Financials Overview

13.1.4 Key Developments

13.1.5 SWOT Analysis

13.2 Thermo Fisher Scientific

13.2.1 Company Overview

13.2.2 Product Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 Illumina

13.3.1 Company Overview

13.3.2 Product Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Bio-Rad Laboratories

13.4.1 Company Overview

13.4.2 Technology/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 QIAGEN N. V

13.5.1 Company Overview

13.5.2 Product Overview

13.5.3 Financial overview

13.5.4 Key Developments

13.5.5 SWOT Analysis

13.6 Abcam

13.6.1 Company Overview

13.6.2 Product Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.6.5 SWOT Analysis

13.7 Becton Dickinson and Company

13.7.1 Overview

13.7.2 Product Overview

13.7.3 Financial Overview

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 Merck Life Sciences

13.8.1 Overview

13.8.2 Product/ Technology Overview

13.8.3 Financials

13.8.4 Key Developments

13.8.5 SWOT Analysis

13.9 Agilent Technologies

13.9.1 Overview

13.9.2 Product Overview

13.9.3 Financials

13.9.4 Key Developments

13.9.5 SWOT Analysis

13.10 Quanterix

13.10.1 Overview

13.10.2 Product Overview

13.10.3 Financials

13.10.4 Key Developments

13.10.5 SWOT Analysis

13.11 Bio-Techne

13.11.1 Overview

13.11.2 Product Overview

13.11.3 Financials

13.11.4 Key Developments

13.11.5 SWOT Analysis

13.12 Olink

13.12.1 Overview

13.12.2 Product Overview

13.12.3 Financials

13.12.4 Key Developments

13.12.5 SWOT Analysis

13.13 Seegene

13.13.1 Overview

13.13.2 Product Overview

13.13.3 Financials

13.13.4 Key Developments

13.13.5 SWOT Analysis

13.14 BioVendor

13.14.1 Overview

13.14.2 Product Overview

13.14.3 Financials

13.14.4 Key Developments

13.14.5 SWOT Analysis

13.15 Others

Chapter 14 MRFR Conclusion

14.1 Key Findings

14.1.1 From CEO’s View Point

14.1.2 Unmet Needs of the Market

14.2 Key Companies to Watch

14.3 Prediction of the Arthroscopy Instruments Industry

Chapter 15 Appendix

LIST OF TABLES

Table 1 Global Singleplex Immunoassay Market Synopsis, 2018–2023

Table 2 Global Singleplex Immunoassay Market Estimates and Forecast, 2018–2023, (USD

Million)

Table 3 Global Singleplex Immunoassay Market, by Region, 2018–2023, (USD Million)

Table 4 Global Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD

Million)

Table 5 Global Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)

Table 6 Global Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)

Table 7 Global Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)

Table 8 Global Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)

Table 9 North America Global Singleplex Immunoassay Market, by Product and Service, 2018–

2023, (USD Million)

Table 10 North America Global Singleplex Immunoassay Market, by Type, 2018–2023, (USD

Million)

Table 11 North America Global Singleplex Immunoassay Market, by Technology, 2018–2023, (USD

Million)

Table 12 North America Global Singleplex Immunoassay Market, by Application, 2018–2023, (USD

Million)

Table 13 North America Global Singleplex Immunoassay Market, by End-User, 2018–2023, (USD

Million)

Table 14 US Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD Million)

Table 15 US Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)

Table 16 US Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)

Table 17 US Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)

Table 18 US Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)

Table 19 Canada Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD

Million)

Table 20 Canada Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)

Table 21 Canada Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)

Table 22 Canada Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)

Table 23 Canada Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)

Table 24 South America Singleplex Immunoassay Market, by Product and Service, 2018–2023,

(USD Million)

Table 25 South America Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)

Table 26 South America Singleplex Immunoassay Market, by Technology, 2018–2023, (USD

Million)

Table 27 South America Singleplex Immunoassay Market, by Application, 2018–2023, (USD

Million)

Table 28 South America Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)

Table 29 Europe Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD

Million)

Table 30 Europe Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)

Table 31 Europe Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)

Table 32 Europe Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)

Table 33 Europe Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)

Table 34 Western Europe Singleplex Immunoassay Market, by Product and Service, 2018–2023,

(USD Million)

Table 35 Western Europe Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)

Table 36 Western Europe Singleplex Immunoassay Market, by Technology, 2018–2023, (USD

Million)

Table 37 Western Europe Singleplex Immunoassay Market, by Application, 2018–2023, (USD

Million)

Table 38 Western Europe Singleplex Immunoassay Market, by End-User, 2018–2023, (USD

Million)

Table 39 Eastern Europe Singleplex Immunoassay Market, by Product and Service, 2018–2023,

(USD Million)

Table 40 Eastern Europe Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)

Table 41 Eastern Europe Singleplex Immunoassay Market, by Technology, 2018–2023, (USD

Million)

Table 42 Eastern Europe Singleplex Immunoassay Market, by Application, 2018–2023, (USD

Million)

Table 43 Eastern Europe Singleplex Immunoassay Market, by End-User, 2018–2023, (USD

Million)

Table 44 Asia Pacific Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD

Million)

Table 45 Asia Pacific Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)

Table 46 Asia Pacific Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)

Table 47 Asia Pacific Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)

Table 48 Asia Pacific Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)

Table 49 Middle East & Africa Singleplex Immunoassay Market, by Product and Service, 2018–

2023, (USD Million)

Table 50 Middle East & Africa Singleplex Immunoassay Market, by Type, 2018–2023, (USD

Million)

Table 51 Middle East & Africa Singleplex Immunoassay Market, by Technology, 2018–2023, (USD

Million)

Table 52 Middle East & Africa Singleplex Immunoassay Market, by Application, 2018–2023, (USD

Million)

Table 53 Middle East & Africa Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Singleplex Immunoassay Market

Figure 3 Segmentation Market Dynamics for Global Singleplex Immunoassay Market

Figure 4 Global Singleplex Immunoassay Market Share, by Product and Service 2017

Figure 5 Global Singleplex Immunoassay Market Share, by Type 2017

Figure 6 Global Singleplex Immunoassay Market Share, by Technology 2017

Figure 7 Global Singleplex Immunoassay Market Share, by Application 2017

Figure 8 Global Singleplex Immunoassay Market Share, by End-User, 2017

Figure 9 Global Singleplex Immunoassay Market Share, by Region, 2017

Figure 10 North America Singleplex Immunoassay Market Share, by Country, 2017

Figure 11 Europe Singleplex Immunoassay Market Share, by Country, 2017

Figure 12 Asia Pacific Singleplex Immunoassay Market Share, by Country, 2017

Figure 13 Middle East & Africa Singleplex Immunoassay Market Share, by Country, 2017

Figure 14 Global Singleplex Immunoassay Market: Company Share Analysis, 2017 (%)

Figure 15 Luminex: Key Financials

Figure 16 Luminex: Segmental Revenue

Figure 17 Luminex: Geographical Revenue

Figure 18 Thermo Fisher Scientific: Key Financials

Figure 19 Thermo Fisher Scientific: Segmental Revenue

Figure 20 Thermo Fisher Scientific: Geographical Revenue

Figure 21 Illumina::Key Financials

Figure 22 Illumina: Segmental Revenue

Figure 23 Illumina: Geographical Revenue

Figure 24 Bio-Rad Laboratories: Key Financials

Figure 25 Bio-Rad Laboratories: Segmental Revenue

Figure 26 Bio-Rad Laboratories: Geographical Revenue

Figure 27 QIAGEN N. V:Key Financials

Figure 28 QIAGEN N. V: Segmental Revenue

Figure 29 QIAGEN N. V. Geographical Revenue

Figure 30 Abcam: Key Financials

Figure 31 Abcam: Segmental Revenue

Figure 32 Abcam: Geographical Revenue

Figure 33 Becton Dickinson and Company: Key Financials

Figure 34 Becton Dickinson and Company: Segmental Revenue

Figure 35 Becton Dickinson and Company: Geographical Revenue

Figure 36 Merck Life Sciences: Key Financials

Figure 37 Merck Life Sciences: Segmental Revenue

Figure 38 Merck Life Sciences: Geographical Revenue

Figure 39 Agilent Technologies: Key Financials

Figure 40 Agilent Technologies: Segmental Revenue

Figure 41 Agilent Technologies: Geographical Revenue

Figure 42 Quanterix: Key Financials

Figure 43 Quanterix: Segmental Revenue

Figure 44 Quanterix: Geographical Revenue

Figure 45 Bio-Techne: Key Financials

Figure 46 Bio-Techne: Segmental Revenue

Figure 47 Bio-Techne: Geographical Revenue

Figure 48 Olink: Key Financials

Figure 49 Olink: Segmental Revenue

Figure 50 Olink: Geographical Revenue

Figure 51 Seegene: Key Financials

Figure 52 Seegene: Segmental Revenue

Figure 53 Seegene: Geographical Revenue

Figure 54 BioVendor: Key Financials

Figure 55 BioVendor: Segmental Revenue

Figure 56 BioVendor: Geographical Revenue